Milan, Italy

Afro Gamba

This inventor holds 1 USPTO granted patent. Top assignee: Isf LLC. Active years: 1979.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Afro Gamba: Innovator in Anti-Ulcer Compounds

Introduction

Afro Gamba is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic applications. His work focuses on innovative solutions to health challenges, showcasing his dedication to improving human well-being.

Latest Patents

Afro Gamba holds a patent for a compound known as 3.beta.-Hydroxy-18.beta.-olean-9-en-30-oic acids. This invention is recognized for its anti-ulcer activity and includes compositions containing the same, along with the processes for their preparation. This patent highlights his commitment to advancing medical science and providing effective treatments.

Career Highlights

Gamba is associated with Isf LLC, where he continues to explore and develop new therapeutic compounds. His work at the company reflects his passion for innovation and his desire to contribute to the pharmaceutical industry. With a focus on practical applications, he aims to bring his inventions to market for the benefit of patients.

Collaborations

Afro Gamba has collaborated with esteemed colleagues such as Giorgio Pifferi and Achille Umani-Ronchi. These partnerships enhance his research efforts and foster a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Afro Gamba is a dedicated inventor whose work in anti-ulcer compounds demonstrates his innovative spirit and commitment to improving health outcomes. His contributions to the field are noteworthy, and his collaborations further enrich the landscape of medicinal research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…